Isotechnika Pharma to be Featured on 21st Century Health Television Series Emailwire (press release) Its lead drug, voclosporin, is an immunosuppressant designed to effectively prevent organ transplant rejection, while providing significant safety advantages over currently available treatments. The Company has successfully completed Phase 2 clinical ... |
